Decompressive craniectomy for malignant middle cerebral artery infarction in a 16-year old boy: a case report
Cryptogenic stroke frequently occurs in younger patients and has a high risk of recurrence. Consequently, secondary prevention is often suboptimal as there is no known risk factor to target. This case demonstrates an unexpected finding of middle cerebral artery infarction and extensive malignant transformation in a 16-year-old boy more than a day post-admission. The lack of a proven culprit lesion makes this case even more intriguing and subsequently raises questions of cryptogenic mechanisms in the context of unrelated trauma.
A 16-year-old white boy had been stabbed in his chest but had a Glasgow Coma Scale score of 15. Over a day later he developed sudden signs and symptoms consistent with a neurological event of unknown etiology. Computed tomography demonstrated significant cerebral edema but was equivocal in its list of differentials. A computed tomography scan of his chest demonstrated no cardiac wall or vascular injury and he was transferred to our neurosurgical unit for intracranial pressure monitoring. A computed tomography angiogram revealed an unexpected finding of malignant middle cerebral artery infarction. Failure to medically manage his intracranial pressure resulted in a decompressive craniectomy less than 12-hours postictus. Despite extensive diagnostic investigations no culprit lesion was identified and no patent foramen ovale found. Since discharge he has returned to full functional status. He was the youngest patient (mean age of 43 years) out of a 10-year institutional retrospective on decompressive craniectomies for malignant middle cerebral artery infarction (n = 40) and had the singularly best Glasgow Outcome Scale score of 5.
This case highlights the preponderance of cryptogenic stroke in younger patients and its etiological elusiveness. It further demonstrates that age is predictive in terms of survival and functional outcome in the context of malignant middle cerebral artery infarction.
KeywordsCryptogenic Decompressive Craniectomy Vasospasm Stroke
Cerebral perfusion pressure
Digital subtraction angiography
Glasgow Coma Scale
Glasgow Outcome Scale
Intensive care unit
Mean arterial blood pressure
Middle cerebral artery
Malignant middle cerebral artery infarction
Medical Research Council
Magnetic resonance imaging
Patent foramen ovale
Randomized controlled trials
Transient ischemic attack
In the UK, stroke is the fourth leading cause of death and the largest cause of complex disability [1, 2]. The incidence of malignant middle cerebral artery infarction (mMCAI) is 1% of all strokes (approximately 1520 patients per annum)  and carries an 80% 30-day mortality if neurosurgical intervention does not occur . With infarction of greater than 50% of middle cerebral artery (MCA) territory, a significant mass effect and concomitant herniation of brain tissue may occur resulting in rapid demise. Recent randomized controlled trials (RCTs) and subsequent meta-analysis make it clear that surgical intervention and subsequent survival and functional outcome are inversely proportional to age . Furthermore, cryptogenic stroke frequently occurs in younger patients and due to it being notoriously difficult to identify a culprit lesion secondary prevention is often suboptimal [1, 2].
A 16-year-old white boy presented due to being stabbed in his chest. He had a blood alcohol level of 145 mg/dL and was hemodynamically compromised but had no head trauma: his Glasgow Coma Scale (GCS) score was 15. A plain chest X-ray (CXR) confirmed a left-sided pneumothorax. Insertion of a 32 Fr chest drain expelled 100 ml of fresh blood. He was admitted under our general surgical team and was making a good recovery.
On the second post-admission day he experienced sudden onset left leg hemiplegia: Medical Research Council (MRC) Grade 1. He was Babinski positive and had hemineglect. He became incontinent of urine, his GCS dropped to 11 (E3 V3 M4), and his pupils were reactive at size 4. An electrocardiogram (ECG) showed ST-segment elevation but his troponin I was not elevated.
A CT scan of his chest demonstrated a potential non-penetrating pericardial injury and pericardial and pleural effusions but no obvious ventricular wall injury. A transthoracic echocardiogram (TTE) revealed no ventricular wall motion derangement. He was intubated for transfer to our neurosurgical intensive care unit (ICU) that morning.
On admission to our neurosurgical ICU he had no eye movements but was localizing to pain. He was not coagulopathic and his mean arterial blood pressure (MAP) was 95 mmHg, an intracranial pressure (ICP) bolt inserted in the ICU recorded an ICP of 38 mmHg, and his cerebral perfusion pressure (CPP) was 57 mmHg.
On the second postoperative day he was localizing to pain but remained hemiplegic. A repeat TTE demonstrated good systolic function and a small pericardial effusion but no tamponade, thrombus, or septal defects. He was extubated on the fifth postoperative day and discharged from ICU.
He made excellent progress over a month and had no focal neurological deficits. Aspirin at 150 mg daily was commenced but not warfarin (as no thrombus was proven). A laboratory examination revealed no lupus anticoagulant and cardiolipin antibodies, no family history of clotting disorders, and a normal cerebrospinal fluid (CSF) protein. A repeat TTE demonstrated no regional wall abnormality (and no septal defects), a bubble test at 4-weeks postictus was normal, and CT angiograms of his aorta and aortic arch were once again both normal. No magnetic resonance imaging (MRI) was conducted based on advice from the stroke physicians because the embolic lesion was clearly visible on CT. At 3-months postictus he was fully independent having a Glasgow Outcome Scale (GOS) score of 5. Three titanium cranioplasties were required over a 3-year period for infective complications. He now drives a car and is in full-time employment.
Cryptogenic stroke accounts for 23 to 45% of all strokes and frequently occurs in younger patients [1, 2, 3, 4, 5]. It has a high risk of recurrence and subsequent incidence of transient ischemic attacks (TIAs). As no clear underlying etiology exists adherence to treatment is often suboptimal (as there is nothing to target). The use of advanced diagnostic techniques includes: long-term monitoring to capture paroxysmal atrial fibrillation (AF); high-resolution MRI to detect plaque, dissection, or vasculitis; and CT angiography to evaluate aortocardiac embolism to identify culprit lesions to target [3, 4].
Due to the cause remaining elusive, his cryptogenic stroke was probably transitory being triggered by his original trauma. This is in keeping with cryptogenic stroke as diagnostic modalities may remain normal even if delayed until after the acute illness has passed [3, 4]. Our patient did not undergo 24-hour Holter monitoring as AF detection rates using this modality are inferior to serial ECGs (these did not reveal AF) and implantable long-term cardiac monitoring was not indicated [4, 5].
Further imaging using TTE and CT angiography excluded cardiac lesions, paradoxical and aortogenic embolism, atrial septal aneurysm, aortic atheroma, and arterial dissection. A patent foramen ovale (PFO) was ruled out on multiple TTEs [4, 5].
Other transitory causes include vasospasm, hypercoagulable states, for example sickle cell disease [3, 4], and migraine-induced stroke [3, 4]. All, except vasospasm, were excluded as he did not undergo digital subtraction angiography (DSA). Consequently, it might remain cryptogenic as TTE is considered the gold standard investigation in the evaluation of cryptogenic stroke (and he had three).
A coagulopathy was excluded and three TTEs were undertaken: the use of transesophageal echocardiography (TEE) is equivocal [4, 5, 6, 7]. Although clinical (for example diabetic), genetic (for example clotting disorders), and electrophysiological (for example premature atrial complexes, left atrial dilatation, and reduced left ventricular ejection fraction) causes were excluded some hematological biomarkers, for example pro-brain natriuretic peptide, were not investigated . According to recent research, these might be predictive for incident AF in cryptogenic stroke . Karaaslan et al.  demonstrated that an etiology can challengingly remain elusive.
Karaaslan et al.  described a case of cryptogenic stroke in a 19-year-old woman undergoing elective laparotomy for resection of a pancreatic pseudopapillary tumor. There had been significant intraoperative blood loss requiring an ICU admission postoperatively. Once extubated 12 hours later she was unable to speak and had a left facial droop. A CT scan of her head demonstrated bilateral thalamic infarcts (subsequently confirmed on MRI) and treatment included anticoagulation. Subsequent investigations including TTEs, TEEs, and genetic, collagen, vascular, and coagulation profile studies failed to identify a potential source of embolic stroke, for example a PFO did not exist, and failed to demonstrate any physiological abnormalities that might have generated a hypercoagulable or coagulable state. She made a full recovery except for minimal memory deficits [7, 8].
Potential sources of our patient’s culprit lesion include a paradoxical embolism because a probe-patent PFO may allow right to left shunting only under specific conditions and toxins as he was found in an isolated street.
This case demonstrates a fact that mMCAI can present in a myriad of ways and is potentially devastating. Although he made a full recovery he remains at high risk of future strokes due to the cryptogenic nature of his original presentation despite being thoroughly investigated (including genetic studies) [3, 5]. Clearly, more research is needed into this particular type of stroke to identify a potential source for culprit lesions as cryptogenic stroke has a predilection for otherwise young healthy patients rendering them to a lifetime of future strokes and serious morbidity.
The authors wish to thank the Department of Neurosurgery at the Institute of Neurological Sciences and the Department of Radiology at the Golden Jubilee Hospital, Clydebank, Scotland.
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Availability of data and materials
The electronic and handwritten case notes, Scottish National Picture Archiving and Communication System (PACS), and operative theatre log books were interrogated to extract the relevant data.
SL extracted clinical details and subsequently prepared the Background, Case presentation, Discussion, and Conclusions sections (and formulated the Figures). PF provided senior trainee guidance and thought-provoking discussion points. MS and SL revised the whole manuscript and double checked it for accuracy and fluency. MS supervised the project. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
Not applicable. Please note: written informed consent was obtained from the patient. This constitutes consent to participate and is cogent to local ethics approval. There was no ethics approval involved in this case report as it was not required.
- 2.Stroke Association. State of the Nation: Stroke Statistics. 2016 (https://www.stroke.org.uk/resources/state-nation-stroke-statistics). Accessed June 2016.
- 4.Bang OY, Ovbiagele B, Kim JS. Evaluation of cryptogenic stroke with advanced diagnostic techniques. Stoke. 2014;45(4):1186–94.Google Scholar
- 7.Patton KK, Heckbert SR, Alonso A, Bahrami H, Lima JA, Burke G, Kronmal RA. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the multi-ethnic study of atherosclerosis: the effects of age, sex and ethnicity. Heart. 2013;99(24):1832–6.CrossRefPubMedGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.